INTELLIA THERAPEUTICS
Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.
INTELLIA THERAPEUTICS
Industry:
Biotechnology Genetics Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.intelliatx.com
Total Employee:
251+
Status:
Active
Contact:
(857) 285-6200
Email Addresses:
[email protected]
Total Funding:
775 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
2seventy bio
2seventy bio is an immuno-oncology cell therapy company that discovers and develops therapies used for cancer treatment.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Chroma Medicine
Chroma Medicine is a new genomic medicine company working on epigenetic editing.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-02-03 | Rewrite Therapeutics | Rewrite Therapeutics acquired by Intellia Therapeutics | N/A |
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Intellia Therapeutics
Janus Capital Group
Janus Capital Group investment in Series B - Intellia Therapeutics
Sectoral Asset Management
Sectoral Asset Management investment in Series B - Intellia Therapeutics
EcoR1 Capital
EcoR1 Capital investment in Series B - Intellia Therapeutics
Foresite Capital
Foresite Capital investment in Series B - Intellia Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Intellia Therapeutics
OrbiMed
OrbiMed investment in Series B - Intellia Therapeutics
Novartis
Novartis investment in Series B - Intellia Therapeutics
Caribou Biosciences
Caribou Biosciences investment in Series A - Intellia Therapeutics
Novartis
Novartis investment in Series A - Intellia Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-26 | Kyverna Therapeutics | Intellia Therapeutics investment in Series B - Kyverna Therapeutics | 85 M USD |
| 2021-10-13 | SparingVision | Intellia Therapeutics investment in Corporate Round - SparingVision | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-16 | Orna Therapeutics Expands Leadership Team with Key Executive Hires |
| 2020-04-30 | Intellia Therapeutics Taps Semma’s Lebwohl as Chief Medical Officer |
Official Site Inspections
http://www.intelliatx.com Semrush global rank: 1.26 M Semrush visits lastest month: 23.7 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
